Stroke, a medical emergency characterized by the sudden onset of neurological deficits due to disrupted blood flow to the brain, requires a deep understanding of its pathophysiology, classification, acute management, and long-term preventive strategies. This article is designed to guide Clinicians through the complexities of stroke management, ensuring they can approach stroke patients with the highest level of clinical acumen.
1. Stroke Pathophysiology: Mechanisms of Brain Injury
Ischemic Stroke
Ischemic stroke, which accounts for 80-85% of all strokes, results from an occlusion of a blood vessel supplying the brain. This occlusion may be due to thrombosis, embolism, or systemic hypoperfusion:
Thrombotic Stroke: Often caused by in-situ arterial plaque rupture, leading to clot formation in the cerebral vasculature.
Embolic Stroke: A clot or debris, usually from the heart (e.g., atrial fibrillation), dislodges and travels to the brain, blocking blood flow.
Lacunar Stroke: Caused by occlusion of small penetrating arteries, often linked to chronic hypertension and diabetes.
Hemorrhagic Stroke
Hemorrhagic strokes make up 15-20% of stroke cases and result from the rupture of a weakened blood vessel in the brain.
Intracerebral Hemorrhage (ICH): Hypertension and amyloid angiopathy commonly cause this form of bleeding within brain parenchyma.
Subarachnoid Hemorrhage (SAH): Most often caused by the rupture of a cerebral aneurysm, this type of stroke presents with sudden, severe headache (the “thunderclap headache”).
2. Stroke Subtypes: The TOAST Classification
The Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification is crucial for ischemic stroke management, providing a framework to categorize strokes based on etiology:
Large-Artery Atherosclerosis (LAA): Typically caused by atherosclerotic plaques in large arteries, such as the internal carotid or middle cerebral artery. Patients often present with cortical symptoms (e.g., aphasia or hemianopia).
Cardioembolism (CE): Arising from a heart-origin embolus, commonly due to atrial fibrillation. These strokes are often severe, involving multiple vascular territories.
Small-Vessel Occlusion (SVO): Involves small perforating arteries, often producing lacunar infarcts in deep brain structures such as the basal ganglia. These strokes present with pure motor or sensory symptoms.
Stroke of Other Determined Etiology (OTH): Includes less common causes such as arterial dissection, vasculitis, or hypercoagulable states.
Stroke of Undetermined Etiology (UND): When no cause is identified after thorough investigation.
Understanding these categories helps guide the choice of secondary prevention strategies, such as anticoagulation for cardioembolic strokes versus antiplatelet therapy for atherosclerotic strokes.
3. Stroke Recognition: Clinical Presentation and Initial Evaluation
Timely recognition of stroke is critical for initiating early treatment. The FAST VAN protocol is an essential tool in emergency settings:
FAST VAN Protocol
Face: Facial asymmetry, with one side drooping.
Arm: Weakness in one arm, unable to hold it up.
Speech: Slurred or difficulty speaking.
Time: Immediate action is crucial.
For large vessel occlusion (LVO), add VAN screening:
Vision: Gaze deviation or visual field deficits.
Aphasia: Difficulty naming objects or understanding speech.
Neglect: Ignoring one side of the body.
B.E.F.A.S.T.
The B.E.F.A.S.T. acronym is an important tool used to quickly recognize the signs of a stroke and take immediate action, especially in emergency situations. Each letter in the acronym represents a critical symptom to watch for:
B: Balance – Sudden loss of balance or coordination, dizziness, or trouble walking.
E: Eyes – Sudden vision changes, such as blurry vision, loss of vision in one or both eyes, or double vision.
F: Face – One side of the face may droop, look uneven, or feel numb.
A: Arm – Weakness or numbness in one arm. When asked to raise both arms, one arm may drift downward.
S: Speech – Slurred or difficult speech, or the inability to speak clearly.
T: Time to Call 1669 – If any of these signs are present, call emergency services immediately, as time is critical in stroke treatment.
B.E.F.A.S.T. is an extended version of the original FAST acronym, which helps laypeople and healthcare professionals rapidly assess a potential stroke and seek urgent medical intervention. This fast action can significantly reduce the risk of death or long-term disability from a stroke by ensuring the patient receives treatment within the "golden hour."
NIH Stroke Scale (NIHSS)
The NIHSS quantifies stroke severity and is pivotal for guiding therapeutic decisions:
NIHSS <5: Mild stroke, often treated with thrombolysis or antiplatelets.
NIHSS >15: Severe stroke, often requiring intensive care and possible mechanical thrombectomy.
Stroke Mimics and Differentials
Common conditions mimicking stroke include hypoglycemia, seizures, migraines, and conversion disorders. Immediate assessment of blood glucose is essential to rule out hypoglycemia.
4. Acute Ischemic Stroke Management: Time-Sensitive Interventions
Time is a critical factor in ischemic stroke management, with the goal of recanalization of the blocked vessel to restore cerebral perfusion.
Intravenous Thrombolysis (rtPA)
rtPA (Alteplase) is the mainstay treatment for ischemic stroke, effective when administered within 4.5 hours of symptom onset.
Dose: 0.9 mg/kg (maximum dose 90 mg), with 10% given as an initial bolus and the remainder infused over 60 minutes.
Contraindications include recent surgery, bleeding diatheses, or stroke within the last 3 months.
Monitoring for hemorrhagic transformation is crucial during and after administration.
Mechanical Thrombectomy
For large vessel occlusion (LVO) strokes, thrombectomy may be performed up to 24 hours post-onset, depending on imaging evidence of salvageable brain tissue. This intervention has revolutionized the care of patients with LVO, offering improved functional outcomes.
5. Hemorrhagic Stroke Management
In hemorrhagic strokes, the goal is to reduce secondary brain injury by controlling blood pressure, managing intracranial pressure (ICP), and addressing the underlying cause.
Blood Pressure Control
For ICH, systolic blood pressure should be reduced to <140 mmHg to minimize hematoma expansion. Agents such as nicardipine or labetalol are preferred.
Surgical Intervention
Craniotomy may be indicated for patients with large hemorrhages causing mass effect or herniation.
Aneurysm Clipping or Coiling: SAH from aneurysms requires urgent neurosurgical intervention to prevent rebleeding.
6. Secondary Prevention: Long-Term Strategies
After the acute phase, preventing stroke recurrence is paramount. Secondary prevention strategies depend on the stroke subtype (e.g., TOAST classification).
Antiplatelet Therapy
Aspirin (81 mg daily) or Clopidogrel (75 mg daily) is recommended for non-cardioembolic strokes.
Dual Antiplatelet Therapy (DAPT): Based on the CHANCE and POINT trials, DAPT (aspirin + clopidogrel) for 21 days reduces the risk of stroke recurrence in patients with minor ischemic stroke or high-risk TIA.
Anticoagulation for Cardioembolism
For cardioembolic strokes (e.g., due to atrial fibrillation), long-term anticoagulation with warfarin (target INR 2-3) or direct oral anticoagulants (DOACs) (e.g., apixaban, rivaroxaban) is necessary to prevent recurrence.
Control of Risk Factors
Hypertension: BP should be maintained below 140/90 mmHg or 130/80 mmHg in high-risk patients.
Diabetes Mellitus: Glycemic control (HbA1c <7.0%) is crucial to prevent small-vessel disease progression.
Dyslipidemia: Initiate high-intensity statins (e.g., atorvastatin 40-80 mg) with a target LDL of <70 mg/dL.
Lifestyle Modifications: Smoking cessation, weight management, and regular exercise are vital to reducing stroke risk.
7. Stroke Rehabilitation and Recovery
Early initiation of rehabilitation can significantly improve long-term outcomes. Comprehensive rehabilitation involves:
Physical Therapy: To improve motor function and mobility.
Speech and Occupational Therapy: For language recovery and activities of daily living (ADLs).
Neuroplasticity: Early and intense rehabilitation promotes neuroplasticity, enhancing recovery by stimulating the brain's ability to reorganize and form new connections.
8. Complications and Monitoring
Hemorrhagic Transformation
Patients receiving rtPA are at risk of hemorrhagic transformation, especially those with large infarcts or hypertension. Close monitoring of neurological status and regular imaging (e.g., CT scan) is essential.
Cerebral Edema
Large hemispheric strokes may result in cerebral edema, requiring treatment with osmotic agents (e.g., mannitol) or decompressive hemicraniectomy.
Seizures
More common in hemorrhagic strokes, seizures should be managed with antiepileptic medications if necessary, though routine prophylaxis is not recommended.
Conclusion
Stroke management at the internal medicine residency level demands a thorough understanding of pathophysiology, timely interventions, secondary prevention, and long-term rehabilitation. The TOAST classification provides essential insights into ischemic stroke etiology, guiding secondary prevention strategies. Early use of rtPA, mechanical thrombectomy, and strict blood pressure control in hemorrhagic strokes can significantly improve outcomes.
Comments